NF-κB: A Stress-Regulated Switch for Cell Survival
- 1 March 2006
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 8 (3-4) , 478-486
Abstract
Nuclear factor-kappaB (NF-kappaB), a stress-regulated transcription factor belonging to the Rel family, has a pivotal role in the control of the inflammatory and the innate immune responses. Its activation rapidly induces the transcription of a variety of genes encoding cell adhesion molecules, inflammatory and chemotactic cytokines, cytokine receptors, and enzymes that produce inflammatory mediators. More recently, NF-kappaB activation has been connected with multiple aspects of oncogenesis, including the control of cell proliferation, migration, cell cycle progression, and apoptosis. Interestingly, NF-kappaB is constitutively activated in several types of cancer cells, including hematological and epithelial malignancies. In addition, activation of NF-kappaB in cancer cells by chemotherapy or radiation therapy has been associated with the acquisition of resistance to apoptosis, which has emerged as a significant impediment to effective cancer treatment. Selective cyclopentenone inhibitors of the IkappaB kinase, the key enzyme controlling NF-kappaB activation, were recently shown to be potent inducers of apoptosis in chemoresistant lymphoid malignancies. Increasing evidence, summarized in this review, indicates that the development of selective NF-kappaB inhibitors may represent a promising therapeutic tool to sensitize tumor cells to apoptosis and increase the efficacy of conventional anticancer drugs in a wide spectrum of malignancies.Keywords
This publication has 76 references indexed in Scilit:
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV ResponseMolecular Cell, 2003
- Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Blood, 2003
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003
- p53 stabilization is decreased upon NFκB activationCancer Cell, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain EnhancerJournal of Biological Chemistry, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Peroxynitrite Inhibits Glutamate Transporter SubtypesJournal of Biological Chemistry, 1996